I hope that the cooperation between packaging producers and pharmaceutical companies continues, especially in terms of co-development activity. Work is needed to improve access to these…
In Conversation
Brain health is not easy science because of the lack of biomarkers. However, with the right team, which I am convinced we have, a company of…
We truly believe that our R&D expertise, partnership appeal and focused go-to-market model make a recipe for success
The positive side of COVID is that it helped accelerate the transformation of healthcare systems into ones with greater agility
[We] are trying to build a global/local mix of expertise to encourage greater numbers of trials to be placed in Saudi Arabia moving forward, which is…
The first of ADL Biopharma’s advantages is our pharma background, which guarantees the highest level of quality and reliability ...
In all of Kyowa Kirin’s daily activities we have a focus on people, both internal and external, and our aim is always to make people smile,…
Tarek El Rahbani – Senior Regional Director, EMEA Growth Emerging Markets – South, Boston Scientific
Our region is still developing, whereby the more we invest, the more training and education we do, the better access we create for patients and the…
Due to the nature of our products, the pandemic represented a huge surge in demand for us
Spain has an extraordinary talent base from which to choose, as well as state-of-the-art universities
The community DSP is building comprises global companies as well as startups and we offer opportunities to companies regardless of where they are in the value…
One in ten generics prescriptions in Spain – more than half of what retail pharmacies dispense to patients – are Teva products
